Search research articles
Contact Us
Filters
Showing results (111-120 of 151) with videos related to
Page
of 16
Sort By:
Cell
|
April 14, 2023
Immune checkpoint therapy-current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Science Signaling
|
January 27, 2026
EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer
Naijiang Liu, Xiaojie Shi, Shao-Rui Chen, et al.
Nature
|
November 11, 2021
Dietary palmitic acid promotes a prometastatic memory via Schwann cells
Gloria Pascual, Diana Domínguez, Marc Elosúa-Bayes, et al.
Annals of Surgical Oncology
|
September 25, 2014
Elective neck dissection in patients with head and neck adenoid cystic carcinoma: an international collaborative study
Moran Amit, Shorook Na'ara, Kanika Sharma, et al.
Head & Neck
|
March 3, 2017
Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study
Moran Amit, Shorook Na'ara, Leonor Trejo-Leider, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 4, 2022
Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology
Moran Amit, Tongxin Xie, Frederico O Gleber-Netto, et al.
Cancer
|
October 12, 2013
Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study
Moran Amit, Tzu-Chen Yen, Chun-Ta Liao, et al.
Cell
|
April 14, 2023
Cancer neuroscience: State of the field, emerging directions
Frank Winkler, Humsa S Venkatesh, Moran Amit, et al.
JCO Precision Oncology
|
June 7, 2023
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer
Hannah Y Chen, Weilu Zhao, Shorook Na'ara, et al.
Head & Neck
|
September 18, 2014
Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system
Ardalan Ebrahimi, Ziv Gil, Moran Amit, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 151) with videos related to
Sort By:
Page
of 16
Cell
|
April 14, 2023
Immune checkpoint therapy-current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Science Signaling
|
January 27, 2026
EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer
Naijiang Liu, Xiaojie Shi, Shao-Rui Chen, et al.
Nature
|
November 11, 2021
Dietary palmitic acid promotes a prometastatic memory via Schwann cells
Gloria Pascual, Diana Domínguez, Marc Elosúa-Bayes, et al.
Annals of Surgical Oncology
|
September 25, 2014
Elective neck dissection in patients with head and neck adenoid cystic carcinoma: an international collaborative study
Moran Amit, Shorook Na'ara, Kanika Sharma, et al.
Head & Neck
|
March 3, 2017
Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study
Moran Amit, Shorook Na'ara, Leonor Trejo-Leider, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 4, 2022
Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology
Moran Amit, Tongxin Xie, Frederico O Gleber-Netto, et al.
Cancer
|
October 12, 2013
Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study
Moran Amit, Tzu-Chen Yen, Chun-Ta Liao, et al.
Cell
|
April 14, 2023
Cancer neuroscience: State of the field, emerging directions
Frank Winkler, Humsa S Venkatesh, Moran Amit, et al.
JCO Precision Oncology
|
June 7, 2023
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer
Hannah Y Chen, Weilu Zhao, Shorook Na'ara, et al.
Head & Neck
|
September 18, 2014
Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system
Ardalan Ebrahimi, Ziv Gil, Moran Amit, et al.
Page
of 16